Injectable dispersion of propofol
AssigneeRTP Pharma Inc.
InventorsGary W. Pace, Michael G. Vachon, Awadesh K. Mishra, Robert A. Snow
Life of this patent
Estimating the term…
Loading patent…
AssigneeRTP Pharma Inc.
InventorsGary W. Pace, Michael G. Vachon, Awadesh K. Mishra, Robert A. Snow
Estimating the term…
A sterile, injectable homogenized dispersion of micromatrices or microdroplets having a mean diameter from about 50 nm to about 1000 nm comprising about 1% to about 7.5% of propofol, about 1% to about 8% of a propofol-soluble diluent, and about 0.67% to about 5% of a surface stabilizing amphiphilic agent suspended in an aqueous medium containing a synergetic quantity of antimicrobial agent and a tonicity modifying amount of a pharmaceutically acceptable water-soluble hydroxyl-group-containing excipient, wherein the ratio of propofol to diluent is in the range of about 0.25 to about 7.5 while the ratio of propofol to amphiphilic agent is in the range from about 0.4 to about 1.5, and wherein the viscosity of the dispersion is in the range of 1.1 to 8 cps, processes for the formation of the dispersion, and methods of use are disclosed.
A sterile, injectable dispersion of micromatrices or microdroplets having a mean diameter from about 50 nm to about 1000 nm comprising:
A sterile, injectable dispersion of micromatrices or microdroplets having a mean diameter from about 50 nm to about 1000 nm comprising:
A sterile, injectable dispersion of micromatrices or microdroplets having a mean diameter from about 50 nm to about 1000 nm comprising:
A sterile, injectable dispersion of micromatrices or microdroplets having a mean diameter from about 50 nm to about 1000 nm comprising:
Dependencies are inferred from the claim text.